Page last updated: 2024-11-05

pyridine-2-aldoxime

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pyridine-2-aldoxime: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135423666
CHEMBL ID77510
SCHEMBL ID8384495
MeSH IDM0169179

Synonyms (70)

Synonym
CHEMBL77510 ,
2-pyridinecarboxaldoxime
nsc66484
2-hydroxyiminomethyl pyridine
picolinealdehyde, oxime
2-pyridylaldoxime
nsc-66484
2-pyridinecarboxaldehyde, oxime
pyridine-2-aldoxime
pyridine-2-aldoximate
p-2-a
picolinaldoxime
p2a
pyridine 2-aldoxime
picolinaldehyde, oxime
2-pyridinealdoxime
2-pyridinaldoxime
ccris 7743
pikolinealdoxime
2-formylpyridine ketoxime
pyrine-2-aldoximate
alpha-picolinealdoxime
pyridine-2-carbaldehyde oxime
2-formylpyridine oxime
einecs 212-849-6
nsc 66484
brn 0109061
AQ-405/40177765
2-pyridinecarbaldehyde oxime
syn-2-pyridinealdoxime, >=99%
AKOS003625743
unii-8pn0640z70
8pn0640z70 ,
5-21-07-00305 (beilstein handbook reference)
1193-96-0
2wfo9n5mqe ,
syn-pyridin-2-aldoxime
(e)-2-pyridinecarboxaldehyde oxime
picolinaldehyde, oxime, (e)-
pyridine-2-aldoxime, (e)-
unii-2wfo9n5mqe
2-pyridinecarboxaldehyde, oxime, (c(e))-
2-pyridinecarboxaldehyde, oxime, (e)-
pyridine-2-carbaldoxime
pyridine-2-carboxaldoxime ,
syn-2-pyridinealdoxime
n-[(pyridin-2-yl)methylidene]hydroxylamine,(e)-n-[(pyridin-2-yl)methylidene]hydroxylamine
FG-0440
SCHEMBL8384495
MTFJSAGADRTKCI-YVMONPNESA-N
(z)-pyridine-2-carbaldehyde oxime
J-640118
STR01308
.alpha.-picolinealdoxime
J-800119
J-802099
F0001-0753
AKOS030241196
J-013843
(ne)-n-(pyridin-2-ylmethylidene)hydroxylamine
2-pyridinecarboxaldehyde,oxime,[c(z)]-
Q27287200
(z)-pyridine-2-aldoxime
A862656
A892577
bdbm50458950
(z)-n-[(pyridin-2-yl)methylidene]hydroxylamine
EN300-1265402
(e)-picolinaldehydeoxime
2-pyridinecarboxaldehyde, oxime, [c(e)]-

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" There was no significant difference between plasma levels and pharmacokinetic parameters of 2-PAM in the two groups of animals, given 2-PAM alone and in conjunction with atropine."( Pharmacokinetics and dosage regimen of 2-pyridine aldoxime in Bubalus bubalis intoxicated with fenitrothion.
Malik, JK; Srivastava, AK, 2001
)
0.31
" Herein, we examine the pharmacokinetic properties of a lead ionizable, zwitterionic hydroxyiminoacetamido alkylamine in mice to develop a framework for studying these agents in vivo and generate sufficient data for their consideration as appropriate antidotes for humans."( Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.
Fokin, VV; Green, C; Kovarik, Z; Maček Hrvat, N; Radić, Z; Sharpless, KB; Sit, RK; Taylor, P; Žunec, S, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" We compared oral and parenteral dosing, and we developed an intramuscular loading and oral maintenance dosing scheme in mice."( Pharmacology, Pharmacokinetics, and Tissue Disposition of Zwitterionic Hydroxyiminoacetamido Alkylamines as Reactivating Antidotes for Organophosphate Exposure.
Fokin, VV; Green, C; Kovarik, Z; Maček Hrvat, N; Radić, Z; Sharpless, KB; Sit, RK; Taylor, P; Žunec, S, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)560.00000.00000.933210.0000AID1385714
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseHomo sapiens (human)Kd402.50000.00801.77505.3000AID1385716; AID1385719; AID1385722; AID1385725
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (13)

Processvia Protein(s)Taxonomy
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1385715Reactivation of VX-inhibited human recombinant AChE assessed as reactivation rate constant incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1226088Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID91473Percentage of mobilization of iron in 2 hours from rat hepatocytes1993Journal of medicinal chemistry, Aug-20, Volume: 36, Issue:17
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
AID1385725Reactivation of ethyl paraoxon-inhibited human recombinant AChE assessed as dissociation constant of inhibited enzyme-compound complex incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385726Reactivation of ethyl paraoxon-inhibited human recombinant AChE assessed as enzyme reactivation by measuring Kr/KD ratio incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1226092Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1385723Reactivation of tabun-inhibited human recombinant AChE assessed as enzyme reactivation by measuring Kr/KD ratio incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID28931Logarithm of cumulative stability constant was determined1993Journal of medicinal chemistry, Aug-20, Volume: 36, Issue:17
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
AID1385714Inhibition of human recombinant AChE by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385722Reactivation of tabun-inhibited human recombinant AChE assessed as dissociation constant of inhibited enzyme-compound complex incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385724Reactivation of ethyl paraoxon-inhibited human recombinant AChE assessed as reactivation rate constant incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385716Reactivation of VX-inhibited human recombinant AChE assessed as dissociation constant of inhibited enzyme-compound complex incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1226086Cytotoxicity against human HepG2.2.15 cells assessed as cell death after 9 days by MTT assay2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1385719Reactivation of NIMP-inhibited human recombinant AChE assessed as dissociation constant of inhibited enzyme-compound complex incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385718Reactivation of NIMP-inhibited human recombinant AChE assessed as reactivation rate constant incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1226089Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion by ELISA2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1385721Reactivation of tabun-inhibited human recombinant AChE assessed as reactivation rate constant incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1226087Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBsAg secretion by ELISA2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID100077Percentage of release of lactic dehydrogenase from rat hepatocytes1993Journal of medicinal chemistry, Aug-20, Volume: 36, Issue:17
Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential.
AID1226091Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBV DNA replication by real-time fluorescence quantitative PCR analysis2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1226090Selectivity index, ratio of CC50 for human HepG2.2.15 cells to IC50 for Hepatitis B virus infected in human HepG2.2.15 cells assessed as inhibition of HBeAg secretion2015European journal of medicinal chemistry, May-05, Volume: 95Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents.
AID1385717Reactivation of VX-inhibited human recombinant AChE assessed as enzyme reactivation by measuring Kr/KD ratio incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
AID1385720Reactivation of NIMP-inhibited human recombinant AChE assessed as enzyme reactivation by measuring Kr/KD ratio incubated for 1 to 10 mins by spectrophotometry based Ellman's assay2018Journal of medicinal chemistry, 09-13, Volume: 61, Issue:17
Structure-Based Optimization of Nonquaternary Reactivators of Acetylcholinesterase Inhibited by Organophosphorus Nerve Agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (41.18)18.7374
1990's4 (11.76)18.2507
2000's5 (14.71)29.6817
2010's9 (26.47)24.3611
2020's2 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.94%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.94%)4.05%
Observational0 (0.00%)0.25%
Other32 (94.12%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]